BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
25. September 2024 11:31 ET
|
BioNexus Gene Lab Corp.
$BGLC signs teaming agreement with Protech Builders to develop Biogas Powerplants
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
13. September 2024 12:05 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC, the “Company”), an emerging biotechnology company focused on innovative healthcare solutions, is...
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
12. September 2024 13:23 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC, the “Company”), an emerging biotechnology company focused on innovative healthcare solutions, is...
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
11. September 2024 11:05 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, the “Company”), an emerging Biotech & Chemicals company, is pleased to announce that its...
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
27. August 2024 11:35 ET
|
BioNexus Gene Lab Corp.
Securities Commission Malaysia Co-Invests with BGLC into AISB Healthcare AI
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
26. August 2024 12:15 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful...
BioNexus Gene Lab Corp. Bersetuju untuk Melabur RM 1.2 juta dalam Ascension Innovation (AISB) untuk Memajukan Inovasi Kesihatan Digital menerusi penerimaan AI dalam Penjagaan Kesihatan
19. April 2024 17:36 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, April 20, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), peneraju global dalam diagnostik genomik dan teknologi penjagaan kesihatan, mengumumkan...
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
18. April 2024 14:52 ET
|
BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
24. Juli 2023 11:30 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials...
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
20. Juli 2023 13:29 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”), an emerging company in the business of selling chemical raw materials in the...